BioLineRx Ltd. (BLRX) AI Dilution Summary

Estimated cash was $14,495,061 as of 2026-08-31, rolled forward from $13,078,000 at the 2026-06-30 balance-sheet date against estimated monthly burn of $916,167. The most recent capital raised was a registered direct offering closed 2026-08-31 with Chardan Capital Markets, LLC as placement agent: $3,750,000 gross for 480,696 shares at $2.78, or $3,300,000 net as filed.